Nutex Health FY2025 revenue up 82% to $875M, diluted EPS $10.48; announces $25M buyback

Nutex Health Inc.

FY2025 total revenue $875.3M, up 82.4% YoY; net income $70.8M vs $52.1M; diluted EPS $10.48 vs $9.69.
Q4 revenue $151.7M (-41.1% YoY) due to $55M arbitration true-up and $69M arbitration revenue recorded in Q4 2024.
Q4 net income $11.8M vs $61.6M; EBITDA $25.7M vs $78.9M; Adjusted EBITDA $16.6M vs $86.7M.
Board authorized $25M stock repurchase program over 6 months to offset dilution from earn-out shares for hospitals.
Remediated all previously disclosed material weaknesses in internal controls over financial reporting in 2025.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

Nutex Health Inc. reported full year 2025 results: revenue $875.3 million, net income $70.8 million, EPS $10.48.

Period: full year 2025
Revenue: $875.3 million
Net income: $70.8 million
EPS: $10.48
Result: reported results

Exact text from the filing

on Form 8-K. --- EX-99.1 (EX-99.1) --- NUTEX HEALTH REPORTS 2025 FINANCIAL RESULTS AND ANNOUNCES SECOND STOCK REPURCHASE PROGRAM FULL YEAR 2025 HIGHLIGHTS: • Total revenue of $875.3 million for the year 2025 versus $479.9 million for the year 2024, an increase of 82.4% • Net income attributable to Nutex Health of $70.8 million for 2025 versus net income of $52.1

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

Nutex Health Inc. reported fourth quarter and year ending December 31, 2025 results: revenue $151.7 million, net income $11.8 million, EPS $10.48.

Period: fourth quarter and year ending December 31, 2025
Revenue: $151.7 million
Net income: $11.8 million
EPS: $10.48
Result: reported results

Exact text from the filing

of $185.6 million, and long-term debt, net of $29.2 million. 1 Financial highlights for the three months ended December 31, 2025 : • Total revenue decreased $105.9 million to $151.7 million for the three months ended December 31, 2025 as compared to total revenue of $257.6 million for the same period in 2024, a decrease of 41.1%. • The Company attributes the $105.9

View on SEC.gov

Browse all earnings releases →

Nutex Health Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-015174

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.